Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q172
SBA

SBA — Single Best Answer · Review

Question 172

Delivery suite → Haemorrhage

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 4850953a-09f1-4748-acdf-d71ad88d0690

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Delivery suite
Topic
Haemorrhage
Subtopic 1
Antepartum haemorrhage
Subtopic 2
Major haemorrhage
Subtopic 3
Coagulopathy
Question Type
SBA

Question

SSBA
Question Header
A woman at 37+6 weeks has a severe placental abruption with continuing haemorrhage. After initial resuscitation she remains tachycardic but her blood pressure has improved. Results show Hb 96 g/L, platelets 58 × 10⁹/L, fibrinogen 0.9 g/L and prolonged PT and APTT. Which management concept is most appropriate?
Question Stem
—

Options

A Correct each abnormal laboratory result sequentially before proceeding to delivery
B Prioritise red cells because haemoglobin is the single best marker of haemorrhage severity
C Continue maternal resuscitation, correct the evolving coagulopathy with appropriate blood components and expedite definitive obstetric management concurrently
D Defer blood-component therapy until repeat results confirm deterioration
E Proceed to delivery without further haemostatic support because removal of the placenta will immediately normalise coagulation

Explanation

Severe abruption with ongoing haemorrhage and evolving consumptive coagulopathy requires integrated, simultaneous management. There is no safe sequential strategy in which resuscitation is completed, laboratory abnormalities are individually normalised and only then is the obstetric cause addressed. Maternal resuscitation, appropriate red-cell and haemostatic blood-component replacement, repeated laboratory assessment and expedited definitive obstetric management must proceed concurrently. The haemoglobin alone does not represent haemorrhage severity, and delivery does not instantly reverse established coagulopathy.

Option Validity

A) Sequential correction risks dangerous delay while haemorrhage and consumption continue.

B) Haemoglobin alone neither measures acute blood-loss severity reliably nor captures the major coagulation abnormalities present.

D) Clinically significant active coagulopathy should not remain untreated while repeat laboratory confirmation is awaited.

E) Delivery addresses the obstetric source but established coagulopathy still requires active correction and surveillance.

Further Reading

RCOG Green-top Guideline No. 63. Antepartum Haemorrhage. Royal College of Obstetricians and Gynaecologists; 2011.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
Site
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question